DD202544A5 - Verfahren zur herstellung von pirbuterol und analoga - Google Patents
Verfahren zur herstellung von pirbuterol und analoga Download PDFInfo
- Publication number
- DD202544A5 DD202544A5 DD82237264A DD23726482A DD202544A5 DD 202544 A5 DD202544 A5 DD 202544A5 DD 82237264 A DD82237264 A DD 82237264A DD 23726482 A DD23726482 A DD 23726482A DD 202544 A5 DD202544 A5 DD 202544A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- tert
- pyridine
- hydroxy
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23292381A | 1981-02-09 | 1981-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD202544A5 true DD202544A5 (de) | 1983-09-21 |
Family
ID=22875140
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD82253605A DD210034A5 (de) | 1981-02-09 | 1982-02-08 | Verfahren zur herstellung von pirbuterol |
| DD82237264A DD202544A5 (de) | 1981-02-09 | 1982-02-08 | Verfahren zur herstellung von pirbuterol und analoga |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD82253605A DD210034A5 (de) | 1981-02-09 | 1982-02-08 | Verfahren zur herstellung von pirbuterol |
Country Status (26)
| Country | Link |
|---|---|
| EP (4) | EP0058072A3 (pl) |
| JP (4) | JPS57150665A (pl) |
| KR (1) | KR860000623B1 (pl) |
| AR (4) | AR231439A1 (pl) |
| AT (2) | ATE21691T1 (pl) |
| AU (1) | AU530826B2 (pl) |
| CA (1) | CA1179677A (pl) |
| CS (1) | CS229678B2 (pl) |
| DD (2) | DD210034A5 (pl) |
| DE (2) | DE3272061D1 (pl) |
| DK (1) | DK157541C (pl) |
| EG (1) | EG16242A (pl) |
| ES (4) | ES509430A0 (pl) |
| FI (1) | FI820396L (pl) |
| GR (1) | GR75867B (pl) |
| GT (1) | GT198273686A (pl) |
| IE (2) | IE52326B1 (pl) |
| IL (1) | IL64954A (pl) |
| NO (4) | NO820371L (pl) |
| NZ (1) | NZ199646A (pl) |
| PH (4) | PH20622A (pl) |
| PL (4) | PL130580B1 (pl) |
| PT (1) | PT74397B (pl) |
| SU (4) | SU1194273A3 (pl) |
| YU (3) | YU42756B (pl) |
| ZA (1) | ZA82778B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3615293A1 (de) * | 1986-05-06 | 1987-11-12 | Bayer Ag | Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3700681A (en) * | 1971-02-16 | 1972-10-24 | Pfizer | 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines |
| BE795937A (fr) * | 1972-03-01 | 1973-08-27 | Pepro | Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee |
| AR207639A1 (es) * | 1973-12-26 | 1976-10-22 | Pfizer | Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica |
| US4031108A (en) * | 1974-10-09 | 1977-06-21 | Pfizer Inc. | 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane |
| US3952101A (en) * | 1975-04-14 | 1976-04-20 | Smithkline Corporation | α-Amino methyl-5-hydroxy-2-pyridinemethanols |
-
1982
- 1982-02-03 SU SU823392299A patent/SU1194273A3/ru active
- 1982-02-04 CS CS82781A patent/CS229678B2/cs unknown
- 1982-02-04 NZ NZ199646A patent/NZ199646A/en unknown
- 1982-02-05 GT GT198273686A patent/GT198273686A/es unknown
- 1982-02-05 GR GR67223A patent/GR75867B/el unknown
- 1982-02-05 AR AR288347A patent/AR231439A1/es active
- 1982-02-08 PT PT74397A patent/PT74397B/pt unknown
- 1982-02-08 DD DD82253605A patent/DD210034A5/de unknown
- 1982-02-08 AU AU80271/82A patent/AU530826B2/en not_active Expired
- 1982-02-08 AT AT82300602T patent/ATE21691T1/de active
- 1982-02-08 CA CA000395768A patent/CA1179677A/en not_active Expired
- 1982-02-08 EP EP82300605A patent/EP0058072A3/en not_active Withdrawn
- 1982-02-08 ZA ZA82778A patent/ZA82778B/xx unknown
- 1982-02-08 EP EP82300604A patent/EP0058071B1/en not_active Expired
- 1982-02-08 IE IE275/82A patent/IE52326B1/en not_active IP Right Cessation
- 1982-02-08 DK DK052182A patent/DK157541C/da not_active IP Right Cessation
- 1982-02-08 AT AT82300604T patent/ATE20882T1/de active
- 1982-02-08 YU YU266/82A patent/YU42756B/xx unknown
- 1982-02-08 DE DE8282300604T patent/DE3272061D1/de not_active Expired
- 1982-02-08 FI FI820396A patent/FI820396L/fi not_active Application Discontinuation
- 1982-02-08 IE IE273/82A patent/IE52325B1/en not_active IP Right Cessation
- 1982-02-08 DD DD82237264A patent/DD202544A5/de not_active IP Right Cessation
- 1982-02-08 ES ES509430A patent/ES509430A0/es active Granted
- 1982-02-08 NO NO820371A patent/NO820371L/no unknown
- 1982-02-08 JP JP57018693A patent/JPS57150665A/ja active Granted
- 1982-02-08 KR KR8200528A patent/KR860000623B1/ko active
- 1982-02-08 DE DE8282300602T patent/DE3272793D1/de not_active Expired
- 1982-02-08 EP EP82300603A patent/EP0058070A3/en not_active Withdrawn
- 1982-02-08 EP EP82300602A patent/EP0058069B1/en not_active Expired
- 1982-02-09 IL IL64954A patent/IL64954A/xx active IP Right Revival
- 1982-02-09 PL PL1982235000A patent/PL130580B1/pl unknown
- 1982-02-09 PH PH26843A patent/PH20622A/en unknown
- 1982-02-09 EG EG60/82A patent/EG16242A/xx active
- 1982-02-09 PL PL1982239427A patent/PL130917B1/pl unknown
- 1982-02-09 PL PL1982239428A patent/PL130918B1/pl unknown
- 1982-02-09 PL PL1982239426A patent/PL130678B1/pl unknown
- 1982-11-17 AR AR291327A patent/AR229373A1/es active
- 1982-11-17 AR AR291329A patent/AR229712A1/es active
- 1982-11-17 AR AR291328A patent/AR229374A1/es active
- 1982-12-20 NO NO824275A patent/NO824275L/no unknown
- 1982-12-20 NO NO824273A patent/NO824273L/no unknown
- 1982-12-20 NO NO824274A patent/NO824274L/no unknown
-
1983
- 1983-01-05 SU SU833534854A patent/SU1250170A3/ru active
- 1983-01-05 SU SU833535711A patent/SU1217253A3/ru active
- 1983-01-05 SU SU833534107A patent/SU1240354A3/ru active
- 1983-01-13 ES ES518971A patent/ES518971A0/es active Granted
- 1983-01-13 ES ES518973A patent/ES518973A0/es active Granted
- 1983-01-13 ES ES518972A patent/ES8403111A1/es not_active Expired
- 1983-10-19 PH PH29713A patent/PH19167A/en unknown
- 1983-10-19 PH PH29712A patent/PH20292A/en unknown
- 1983-10-19 PH PH29714A patent/PH19164A/en unknown
-
1984
- 1984-11-28 YU YU2019/84A patent/YU42908B/xx unknown
- 1984-11-28 YU YU2018/84A patent/YU43389B/xx unknown
-
1985
- 1985-01-23 JP JP60010723A patent/JPS6059911B2/ja not_active Expired
- 1985-01-23 JP JP60010724A patent/JPS6059231B2/ja not_active Expired
- 1985-10-09 JP JP60225922A patent/JPS6193164A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60004087T2 (de) | Verfahren und zwischenprodukte zur herstellung von imidazolinon alpha v integrin antagonisten | |
| EP0606065B1 (de) | Verfahren zur Herstellung von Biphenylderivaten | |
| EP1049674B1 (de) | Verfahren zur herstellung von (-)cis-3- hydroxy-1- methyl-4-(2, 4,6-trimethoxyphenyl)- piperidin | |
| DE68922936T2 (de) | Verfahren zur Herstellung von Serinol. | |
| DE2609015C2 (de) | Verfahren zur Herstellung von Benz (f)-2,5-oxazocinen | |
| EP1073634B1 (de) | Verfahren zur herstellung von enantiomerenreinem n-methyl- n- (1s)- 1-phenyl- 2-((3s)-3- hydroxypyrrolidin- 1-yl)ethyl]- 2,2- diphenylacetamid | |
| DE2750553C2 (de) | Verfahren zur Herstellung von gamma-Pyronen | |
| DD202544A5 (de) | Verfahren zur herstellung von pirbuterol und analoga | |
| CH619700A5 (pl) | ||
| US4031108A (en) | 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane | |
| DE69016647T2 (de) | Verfahren zur herstellung von alpha-beta-ungesättigten ketonen. | |
| KR930008231B1 (ko) | 플루오로메틸-치환 피페리딘 카보디티오에이트의 제조방법 | |
| DE2452536A1 (de) | Pyrrolidone und verfahren zu ihrer herstellung | |
| DE69126326T2 (de) | Verfahren und Zwischenprodukte zur Herstellung von anxiolytisch wirksamen Perhydro-1H-pyrido[1,2-a]pyrazinen | |
| DE69200717T2 (de) | Verfahren zur Herstellung von N,N-Dihydrocarbylhydroxylaminen. | |
| EP0177448B1 (de) | Verfahren zur Herstellung von 1,2-Benzoxathiin-Derivaten | |
| DE2034682A1 (de) | Herstellung von eis 1 Propenylphos phonsaure | |
| EP0171046B1 (de) | Verfahren zur Herstellung von Pantolacton | |
| DE2461307A1 (de) | Verfahren zur herstellung von 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy- 2-t-butylaminoaethyl)pyridin und zwischenverbindungen | |
| EP0423595B1 (de) | Verfahren zur Herstellung von 3-Trichlormethyl-pyridin | |
| EP0087654B1 (de) | Verfahren zur Herstellung von 1-(4-Chlorbenzoyl)-5-methoxy-2-methyl-3-indolacetoxyessigsäure | |
| JP3382681B2 (ja) | 含フッ素化合物およびその製法 | |
| DE19533219A1 (de) | Verfahren zur Herstellung von N-Alkenylcarbaminsäureestern | |
| US4477671A (en) | 3-Acetoxy or benzyloxy-2-acetoxymethyl-6-[1-acetoxy-2-(N-tert-butylacetamido)ethyl]pyridine intermediates | |
| EP0354301A2 (de) | Verfahren zur Herstellung von Chinuclidin-3-methanol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |